🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall objective of this study is to determine an optimal dose and dos...
Status
Completed
Location
Pearl Investigative Site
Start Date
2012-03
Trial ID
NCT01566773
Treatments Being Tested
This randomized, cross over study aims to find out the benefits of deliveri...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-20
Trial ID
NCT03227445
Treatments Being Tested
GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-12-12
Trial ID
NCT00279019
Treatments Being Tested
This is a multiple dose, randomized, parallel, double-blind, double-dummy, ...
Status
Completed
Location
Research Site
Start Date
2016-07-05
Trial ID
NCT02796677
This is a Phase IV multi-center, randomized, open-label, cross-over, placeb...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-21
Trial ID
NCT02786927
The purpose of this study is to assess the safety and tolerability of singl...
Status
Completed
Location
Quintiles Drug Research Unit at Guy's Hospital
Start Date
2013-09-01
Trial ID
NCT02059434
COPD is a progressive disease characterized by increasing obstruction to ai...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-03-29
Trial ID
NCT03474081
This is a randomized, multi-centre, open-label, placebo-device, cross-over ...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-12-30
Trial ID
NCT02982187
Treatments Being Tested
The purpose of this study is to determine steady-state efficacy and dose re...
Status
Completed
Location
Elevation Investigational Site
Start Date
2011-08
Trial ID
NCT01426009
This is a Phase IIIb multicentre, randomised, blinded, triple dummy, parall...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-10-15
Trial ID
NCT02257385